Sio2 Medical Products, Inc.

Formycon Ag

Klinge Biopharma Gmbh

Si02 Medical Products, Inc.

Murray Stephen Bennett

Jean-Pierre Giraud

Christopher Weikart

Carsten Brockmeyer

Thomas Strungmann

Thomas STRÜNGMANN

A pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist, for example Ranibizumab, in a pre-filled pharmaceutical package, for example a syringe, cartridge, or vial, made in part or in whole of a thermoplastic polymer, coated on the interior with a tie coating or layer, a barrier coating or layer, a pH protective coating or layer, and optionally a lubricity coating or layer. Stability performance of the VEGF-antagonist packaged in the coated COP vessel comparable to or better than glass was obtained.

Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist

A liquid formulation of an ophthalmic drug in a pharmaceutical package, for example a syringe, cartridge, or vial, made in part or in whole of a thermoplastic polymer, coated on the interior with a tie coating or layer, a barrier coating or layer, a pH protective coating or layer, and optionally a lubricity coating or layer.

Pharmaceutical package for ophthalmic formulations

Growing community of inventors

Bellingham, WA, United States of America

Murray Stephen Bennett